---
figid: PMC11967254__CAS-116-853-g004
figtitle: Metabolic pathway of azacitidine (AZA) and decitabine (DAC)
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC11967254
filename: CAS-116-853-g004.jpg
figlink: /pmc/articles/PMC11967254/figure/F1/
number: F1
caption: Metabolic pathway of azacitidine (AZA) and decitabine (DAC). AZA and DAC
  undergo multi‐step phosphorylation and are incorporated into DNA and RNA. DAC incorporates
  into DNA more efficiently than AZA, resulting in DNA hypomethylation via DNMT1 depletion
papertitle: Treating Hematological Malignancies With OR‐2100, an Orally Bioavailable
  Prodrug of Decitabine
reftext: Tatsuro Watanabe, et al. Cancer Sci. 2025 Apr;116(4).
year: '2025'
doi: 10.1111/cas.16452
journal_title: Cancer Science
journal_nlm_ta: Cancer Sci
publisher_name: Wiley
keywords: combination therapy | DNA demethylating agents | DNA methylation | hematological
  malignancies | prodrug
automl_pathway: 0.9293029
figid_alias: PMC11967254__F1
figtype: Figure
redirect_from: /figures/PMC11967254__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11967254__CAS-116-853-g004.html
  '@type': Dataset
  description: Metabolic pathway of azacitidine (AZA) and decitabine (DAC). AZA and
    DAC undergo multi‐step phosphorylation and are incorporated into DNA and RNA.
    DAC incorporates into DNA more efficiently than AZA, resulting in DNA hypomethylation
    via DNMT1 depletion
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Azacitidine
  - RNA
  - DNA
  - Decitabine
---
